Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-01-15 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VIGNEUX-SUR-SEINE (91270), Essonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU MARCHE : revenue, balance sheet and financial ratios
PHARMACIE DU MARCHE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VIGNEUX-SUR-SEINE (91270),
this company of category PME
shows in 2024 a net income positive of 213 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MARCHE (SIREN 844889840)
Indicator
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
213 106 €
189 932 €
55 984 €
127 130 €
126 599 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU MARCHE generates positive net income of 213 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 127 k€ -> 213 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
213 106 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 552%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 14%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
552.054%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
14.053%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
Debt ratio
202.877
164.354
705.364
388.416
552.054
Financial autonomy
27.431
33.734
11.228
16.989
14.053
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
552.052024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE DU MARCHE (552.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
14.05%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of PHARMACIE DU MARCHE (14.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 693.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
693.825
Liquidity indicators evolution PHARMACIE DU MARCHE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
Liquidity ratio
77.303
163.363
198.77
180.892
693.825
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
693.832024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent+25 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU MARCHE (693.83) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DU MARCHE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU MARCHE is estimated at
2 975 117 €
(range 2 071 824€ - 4 450 945€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2071k€2975k€4450k€
2 975 117 €Range: 2 071 824€ - 4 450 945€
NAF 5 année 2024
Valuation method used
Net Income Multiple
213 106 €
×
14.0x
=2 975 117 €
Range: 2 071 825€ - 4 450 946€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MARCHE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MARCHE
What is the revenue of PHARMACIE DU MARCHE ?
The revenue of PHARMACIE DU MARCHE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU MARCHE profitable?
Yes, PHARMACIE DU MARCHE generated a net profit of 213 k€ in 2024.
Where is the headquarters of PHARMACIE DU MARCHE ?
The headquarters of PHARMACIE DU MARCHE is located in VIGNEUX-SUR-SEINE (91270), in the department Essonne.
Where to find the tax return of PHARMACIE DU MARCHE ?
The tax return of PHARMACIE DU MARCHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MARCHE operate?
PHARMACIE DU MARCHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart